NIH Funding Delays Threaten HIV Clinical Trial Infrastructure

Experts warn that delays in renewing funding for National Institutes of Health (NIH)-supported HIV clinical trial networks could severely disrupt ongoing research. This situation risks the loss of experienced staff and the erosion of critical research infrastructure developed over decades, potentially hindering future advancements in HIV treatment and prevention.